Neurotransmitters are essential to your body's intricate neural system. Among them, dopamine stands out for its profound ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...

Now, new research from the Warren Center for Neuroscience Drug Discovery (WCNDD) offers hope. Scientists have identified a ...

The creation of a “Make America Healthy Again Commission” has raised concerns over Washington youths' access to medications ...

Investigational drug SPN-820, which activates the mTORC1 pathway, failed to significantly reduce depressive symptoms compared ...

Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

the treatment of schizophrenia has relied almost entirely on drugs that block dopamine D2 receptors, but NBI-1117568 is one of a series of new therapies emerging from the pharma industry pipeline ...

Upheaval within the brain’s higher order networks could explain psilocybin users’ feelings of profound connection to the ...